Senior Test Engineer, Selections and Strain Improvement

---

Job description

Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe's growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms. Today, our foundry is developing over 40 different organisms to make different products across multiple industries.The focus of the Selections & Strain Improvement (SSI) team is the application of directed evolution to achieve strain engineering objectives. In support of this mission you will: (1) design and construct genetic libraries of genes, pathways, and whole genomes, (2) develop and deploy genetic selections to improve production of target biomolecules, (3) develop and deploy multiplex cell-based assays, and (4) develop novel methods of ultra-high-throughput screening for phenotypes of interest. We are always seeking to get the job done faster, better, and cheaper. We are looking for help in doing that.ResponsibilitiesMeet with stakeholders to understand needs and decide on deliverables, and then follow up and share results with themPlan and execute multi-month directed evolution and/or strain engineering campaignsCollaborate within the SSI team and with other Ginkgo teamsDevelop protocols and write SOPsDesired Experience and CapabilitiesPhD or equivalentDeep experience in molecular biology, genetics, and/or synthetic biologyDemonstrated success in deploying one or more of the following: NGS analysis, FACS, directed evolution, cell-free systems, and genome editingWillingness to learn and use a variety of automation and software tools, including code and Ginkgo software under active developmentTo learn more about Ginkgo, check out some recent press:What is it really like to take your company public via a SPAC? One Boston biotech shares its journey (Fortune)Ginkgo Bioworks resizes the definition of going big in biotech, raising $2.5B in a record SPAC deal that weighs in with a whopping $15B-plus valuation (Endpoints News)Ginkgo Bioworks CEO on scaling up Covid-19 testing: 'If we try, we can win' (CNBC)Ginkgo raises $70 million to ramp up COVID-19 testing for employers, universities (Boston Globe)Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus (Wall Street Journal)Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response (PRNewswire)The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize Manufacturing (Forbes)Synthetic Bio Pioneer Ginkgo Raises $290 Million in New Funding (Bloomberg)Ginkgo Bioworks raises $350 million fund for biotech spinouts (Reuters)Can This Company Convince You to Love GMOs? (The Atlantic)We also feel that it's important to point out the obvious here there's a serious lack of diversity in our industry, and that needs to change. Our goal is to help drive that change. Ginkgo is deeply committed to diversity, equity, and inclusion in all of its practices, especially when it comes to growing our team. Our culture promotes inclusion and embraces how rewarding it is to work with people from all walks of life.We're developing a powerful biological engineering platform, so we must remain mindful of the many ways our technology can and will impact people around the world. We care about how our platform is used, and having a diverse team to build it gives us the best chance that it's something we'll be proud of as it continues to grow. Therefore, it's critical that we incorporate the diverse voices and visions of all those who play a role in the future of biology.It is the policy of Ginkgo Bioworks to provide equal employment opportunities to all employees and employment applicants.Apply for this job

<!– job description page –>